| Juliet Eunhe Chung, MD | |
|
1807 Wilshire Blvd Ste 203, Santa Monica, CA 90403-5790 | |
| (310) 829-0160 | |
| (310) 829-0170 |
| Full Name | Juliet Eunhe Chung |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 1807 Wilshire Blvd Ste 203, Santa Monica, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780842245 | NPI | - | NPPES |
| GR0061481 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0009X | Ophthalmology - Glaucoma Specialist | A103193 (California) | Secondary |
| 207W00000X | Ophthalmology | A103193 (California) | Primary |
| Entity Name | County Of Los Angeles |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851363188 PECOS PAC ID: 1850296534 Enrollment ID: O20031204001218 |
News Archive
A study performed at Children's Hospital Los Angeles found no evidence that stem cell therapy improves vision for children with optic nerve hypoplasia. Their results are reported in the Journal of the American Association for Pediatric Ophthalmology and Strabismus.
Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new way of identifying fresh market applications for drugs nearing the end of their product lifecycle.
The work, which is published in the journal Occupational and Environmental Medicine, was carried out under the Fifth Framework Programme (FP5) Geoparkinson project, which aimed to investigate how genetic and environmental factors interact to cause Parkinson's disease and related conditions.
Over the last few years, researchers have used a type of brain scanning, known as functional magnetic resonance imaging fMRI, to help them map changes in blood flow in the brain and to correlate this with thoughts and behavior. A new way to analyze fMRI data, which could improve is reported in the International Journal of Computational Biology and Drug Design.
A particular human gene variant makes breast cancer cells more aggressive. Not only are these more resistant to chemotherapy but also leave the primary tumour and establish themselves in other parts of the body in the form of metastases. An international group of researchers led by Lukas Kenner of MedUni Vienna has now identified a gene, AF1q, as being substantially responsible for this and recognized it as a possible starting point for more accurate diagnosis and potential targeted therapeutic approaches.
› Verified 2 days ago
| Entity Name | Jules Stein Eye Institute Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326006966 PECOS PAC ID: 5597663740 Enrollment ID: O20031223000884 |
News Archive
A study performed at Children's Hospital Los Angeles found no evidence that stem cell therapy improves vision for children with optic nerve hypoplasia. Their results are reported in the Journal of the American Association for Pediatric Ophthalmology and Strabismus.
Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new way of identifying fresh market applications for drugs nearing the end of their product lifecycle.
The work, which is published in the journal Occupational and Environmental Medicine, was carried out under the Fifth Framework Programme (FP5) Geoparkinson project, which aimed to investigate how genetic and environmental factors interact to cause Parkinson's disease and related conditions.
Over the last few years, researchers have used a type of brain scanning, known as functional magnetic resonance imaging fMRI, to help them map changes in blood flow in the brain and to correlate this with thoughts and behavior. A new way to analyze fMRI data, which could improve is reported in the International Journal of Computational Biology and Drug Design.
A particular human gene variant makes breast cancer cells more aggressive. Not only are these more resistant to chemotherapy but also leave the primary tumour and establish themselves in other parts of the body in the form of metastases. An international group of researchers led by Lukas Kenner of MedUni Vienna has now identified a gene, AF1q, as being substantially responsible for this and recognized it as a possible starting point for more accurate diagnosis and potential targeted therapeutic approaches.
› Verified 2 days ago
| Entity Name | Advanced Vision Care A California General Partnership |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073816070 PECOS PAC ID: 1658553722 Enrollment ID: O20110310000415 |
News Archive
A study performed at Children's Hospital Los Angeles found no evidence that stem cell therapy improves vision for children with optic nerve hypoplasia. Their results are reported in the Journal of the American Association for Pediatric Ophthalmology and Strabismus.
Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new way of identifying fresh market applications for drugs nearing the end of their product lifecycle.
The work, which is published in the journal Occupational and Environmental Medicine, was carried out under the Fifth Framework Programme (FP5) Geoparkinson project, which aimed to investigate how genetic and environmental factors interact to cause Parkinson's disease and related conditions.
Over the last few years, researchers have used a type of brain scanning, known as functional magnetic resonance imaging fMRI, to help them map changes in blood flow in the brain and to correlate this with thoughts and behavior. A new way to analyze fMRI data, which could improve is reported in the International Journal of Computational Biology and Drug Design.
A particular human gene variant makes breast cancer cells more aggressive. Not only are these more resistant to chemotherapy but also leave the primary tumour and establish themselves in other parts of the body in the form of metastases. An international group of researchers led by Lukas Kenner of MedUni Vienna has now identified a gene, AF1q, as being substantially responsible for this and recognized it as a possible starting point for more accurate diagnosis and potential targeted therapeutic approaches.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Juliet Eunhe Chung, MD 5767 W Century Blvd Ste 400, Los Angeles, CA 90045-5631 Ph: () - | Juliet Eunhe Chung, MD 1807 Wilshire Blvd Ste 203, Santa Monica, CA 90403-5790 Ph: (310) 829-0160 |
News Archive
A study performed at Children's Hospital Los Angeles found no evidence that stem cell therapy improves vision for children with optic nerve hypoplasia. Their results are reported in the Journal of the American Association for Pediatric Ophthalmology and Strabismus.
Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new way of identifying fresh market applications for drugs nearing the end of their product lifecycle.
The work, which is published in the journal Occupational and Environmental Medicine, was carried out under the Fifth Framework Programme (FP5) Geoparkinson project, which aimed to investigate how genetic and environmental factors interact to cause Parkinson's disease and related conditions.
Over the last few years, researchers have used a type of brain scanning, known as functional magnetic resonance imaging fMRI, to help them map changes in blood flow in the brain and to correlate this with thoughts and behavior. A new way to analyze fMRI data, which could improve is reported in the International Journal of Computational Biology and Drug Design.
A particular human gene variant makes breast cancer cells more aggressive. Not only are these more resistant to chemotherapy but also leave the primary tumour and establish themselves in other parts of the body in the form of metastases. An international group of researchers led by Lukas Kenner of MedUni Vienna has now identified a gene, AF1q, as being substantially responsible for this and recognized it as a possible starting point for more accurate diagnosis and potential targeted therapeutic approaches.
› Verified 2 days ago
Donald E Dickerson, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1908 Santa Monica Blvd, Suite 3, Santa Monica, CA 90404 Phone: 310-829-5475 Fax: 310-828-1359 | |
Brenda Nuyen, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1908 Santa Monica Blvd, Ste 3, Santa Monica, CA 90404 Phone: 310-829-5475 | |
Dr. Thomas Alan Hanscom, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2021 Santa Monica Blvd, Suite # 720e, Santa Monica, CA 90404 Phone: 310-829-3303 Fax: 310-829-3301 | |
Howard R Krauss, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2125 Arizona Ave, Santa Monica, CA 90404 Phone: 310-829-8701 Fax: 310-315-4062 | |
Gavin Bahadur, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1807 Wilshire Blvd, Suite 203, Santa Monica, CA 90403 Phone: 310-829-0160 Fax: 310-829-0170 | |
Reza Alizadeh, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1807 Wilshire Blvd Ste 203, Santa Monica, CA 90403 Phone: 310-829-0160 | |
Dr. Troy Elander, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 242 26th St, Santa Monica, CA 90402 Phone: 310-393-0634 Fax: 310-451-4009 |